Imbio PHA (4.0.0) vs uOmnispace.MR
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is rapid, automated analysis of CT pulmonary angiogram (CTPA) scans for assessing potential right ventricular dilation. This tool is specifically designed to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing precise measurements of cardiac structures and ratios.
View Imbio PHA (4.0.0) →Choose uOmnispace.MR if…
Choose uOmnispace.MR if you require a comprehensive AI-powered solution for advanced magnetic resonance (MR) image analysis across diverse clinical applications, including brain, breast, and cardiac imaging. This software offers a wide array of post-processing tools, such as AI-driven cardiac ventricular segmentation, MR Spectroscopy, and perfusion analysis, for detailed diagnostic insights beyond basic cardiac measurements.
View uOmnispace.MR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | uOmnispace.MR |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA emphasizes rapid, fully-automated assessment and seamless integration into existing DICOM workflows, generating annotated images and PDF reports. This focus on automation and integration for a specific task generally translates to higher usability by minimizing user intervention and fitting into current clinical practices. uOmnispace.MR offers comprehensive features across multiple modalities, which, while powerful, might imply a steeper learning curve for its full capabilities.
Clinical Value
uOmnispace.MRuOmnispace.MR offers broader clinical value by supporting diverse applications across multiple specialties, including brain, breast, and cardiac imaging, and various MR modalities like spectroscopy, perfusion, and vessel analysis. This versatility allows it to address a wider range of diagnostic needs within an institution. Imbio PHA, while highly valuable, is specialized for assessing right ventricular dilation from CTPA scans for pulmonary embolism and hypertension.
Pricing & Value
TieBoth Imbio PHA and uOmnispace.MR require direct contact for pricing information. Without transparent pricing details or specific value propositions, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value. Therefore, a definitive winner cannot be determined in this dimension.
Enterprise Readiness
Imbio PHA (4.0.0)Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and flexible deployment options (cloud, on-premise, hybrid). However, Imbio PHA explicitly highlights its third-party HIPAA certification by Compliancy Group and offers 24/7/365 support for all customers worldwide, providing a slight edge in documented enterprise-grade assurances and continuous operational support.
Innovation
uOmnispace.MRuOmnispace.MR appears more innovative due to its broader application of AI across multiple MR modalities and diverse advanced post-processing techniques, including MR Spectroscopy, perfusion analysis, vessel analysis, and full-format image stitching. It also utilizes deep learning for spine and rib labeling. While Imbio PHA offers impactful automation for a specific clinical need, uOmnispace.MR's wider array of AI-driven features suggests a greater breadth of innovation.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA provides transparent and specific details regarding its support, including phone and email channels, defined support hours (8:00 AM u2013 6:00 PM CST), and 24/7/365 monitoring for email and website support tickets. It also states that user manuals and product documentation are available upon request. While Shanghai United Imaging Healthcare has a global presence, specific details about uOmnispace.MR's ongoing customer support availability and documentation access are less explicitly stated.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | uOmnispace.MR |
|---|---|---|
| Name | Imbio PHA (4.0.0) | uOmnispace.MR |
| Company | Imbio | Shanghai United Imaging Healthcare Co., Ltd. |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation. |
| Imaging Modality | CT pulmonary angiogram (CTPA) | Magnetic Resonance (MR) |
| Key Features (Cardiac) | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement | AI-driven cardiac ventricular segmentation; Cardiac function analysis |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Neurology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and uOmnispace.MR.